Abingworth LLP
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Abingworth LLP - overview
Established
1973
Location
London, England, UK
Primary Industry
Financial Services
About
Founded in 1973 and based in London, UK, Abingworth LLP operates as a life sciences investment firm that focuses on healthcare, information technology, life sciences, and technology-based industries. In April 2022, Carlyle Group agreed to acquire Abingworth LLP. As of 2022, Kurt von Emster is the managing director of the company. The company assists in the translation of cutting-edge technology into medicines by giving funding and experience to management teams establishing world-class firms.
The firm has invested in over 175 life science companies including 46 mergers and acquisitions and more than 70 initial public offerings. Abingworth invests in three types of therapeutics: seed and early-stage, development stage, and clinical co-development.
Current Investors
Carlyle Group
Primary Industry
Financial Services
Sub Industries
Investment Banking, Private Equity, Biotechnology
Website
www.abingworth.com
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Abingworth LLP - timeline of key events
Abingworth LLP - financials
| Fiscal Year Ended | Jun 30, 2012 | Jun 30, 2013 | Jun 30, 2014 | Jun 30, 2015 | Jun 30, 2016 | Jun 30, 2017 | Jun 30, 2018 | Jun 30, 2019 | Jun 30, 2020 | Jun 30, 2021 | Jun 30, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 13,774,918 | 15,392,982 | 17,720,144 | 13,670,291 | 11,315,798 | 9,828,031 | 14,684,721 | 12,478,524 | 10,244,116 | 14,506,606 | 20,566,849 | - | - | - |
| % Revenue Growth (YoY) | - | 11.7% | 15.1% | (22.9%) | (17.2%) | (13.1%) | 49.4% | (15.0%) | (17.9%) | 41.6% | 41.8% | - | - | - |
| EBITDA (USD) | 6,001,744 | 7,816,064 | 9,201,443 | 6,960,563 | 4,424,506 | 2,572,534 | 5,052,539 | 4,818,680 | 1,616,579 | 5,916,572 | 9,063,391 | - | - | - |
| Operating Income (USD) | 5,895,532 | 7,695,725 | 9,082,810 | 6,843,218 | 4,279,575 | 2,423,889 | 4,953,407 | 4,729,845 | 1,526,774 | 5,839,167 | 8,985,753 | - | - | - |
| Operating Margin | 42.8% | 50.0% | 51.3% | 50.1% | 37.8% | 24.7% | 33.7% | 37.9% | 14.9% | 40.3% | 43.7% | - | - | - |
| % EBITDA Margin | 43.6% | 50.8% | 51.9% | 50.9% | 39.1% | 26.2% | 34.4% | 38.6% | 15.8% | 40.8% | 44.1% | - | - | - |
| NET Income (USD) | 5,838,275 | 7,746,601 | 8,973,934 | 6,798,197 | 4,181,133 | 2,343,055 | 4,848,910 | 4,646,319 | 1,469,726 | 5,774,353 | 8,905,262 | - | - | - |
| % Net Margin | 42.4% | 50.3% | 50.6% | 49.7% | 36.9% | 23.8% | 33.0% | 37.2% | 14.3% | 39.8% | 43.3% | - | - | - |
Abingworth LLP - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Abingworth LLP | - |
Displaying 1 - 1 of 1
Abingworth LLP - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.